Production and purification of recombinant monoclonal antibodies from human cells based on a primary sequence

There are challenges to using commercially available antibodies generated in animals, including concerns with reproducibility, high costs, and ethical issues. Here, we present a protocol for generating and purifying recombinant antibodies from human HEK293 suspension culture cells from a primary seq...

Descripción completa

Detalles Bibliográficos
Autores principales: DeLuca, Keith F., Mick, Jeanne E., DeLuca, Jennifer G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763751/
https://www.ncbi.nlm.nih.gov/pubmed/36595892
http://dx.doi.org/10.1016/j.xpro.2022.101915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763751/
https://www.ncbi.nlm.nih.gov/pubmed/36595892
http://dx.doi.org/10.1016/j.xpro.2022.101915

Ejemplares similares